ampriwest 50 mg lyophilized powder for injection (iv)
ambica international corporation; distributor: central west medicale inc. - amphotericin b - lyophilized powder for injection (iv) - 50 mg
amphizone 50 mg lyophilized powder for injection (iv)
ambica international corporation; distributor: ambica international corporation - amphotericin b - lyophilized powder for injection (iv) - 50 mg
amphotret 50mg parenteral ordinary vials
bharat serums and vaccines ltd - amphotericin b - parenteral ordinary vials - 50mg
ambisome liposomal pdr/conc/soln for infus 50mg
gilead sciences international limited - amphotericin b - powder for concentrate for dispersion for infusion - amphotericin b 50 mg - antimycotics for systemic use
ampho-b 50mg
vhb medi sciences limited - amphotericin-b for injection, usp - lyophilized powder for injection - 50 mg/vial
cordarone x intravenous 150mg/3ml injection
sanofi-aventis australia pty ltd - amiodarone hydrochloride, quantity: 150 mg - injection, solution - excipient ingredients: polysorbate 80; benzyl alcohol; water for injections - severe cases of tachyarrhythmias (eg. wolff-parkinson-white syndrome, supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation. cordarone x intravenous may be used for treatment initiated in a hospital for severe cases of tachyarrhythmias (atrial, junctional and ventricular) not responding to other therapy and when a rapid response is required. cordarone x intravenous should only be used where facilities exist for cardiac monitoring and defibrillation should the need arise
vancocin vancomycin 250mg (250,000iu as hydrochloride) capsule blister pack
aspen pharmacare australia pty ltd - vancomycin hydrochloride, quantity: 256 mg (equivalent: vancomycin, qty 250 mg) - capsule - excipient ingredients: iron oxide black; titanium dioxide; indigo carmine; iron oxide red; gelatin; macrogol 6000 - this product accepted for registration as 'currently supplied' at the time of commencement of the act. revision of product information was approved as specified in the letter of 13 august 1992 from dr alex proudfoot advising of approval for registration of the goods. indicated for staphylococcal enterocolitis and antibiotic - associated pseudomembranous colitis produced by c. difficile.
rythmodan disopyramide 150 mg capsule blister pack
pharmaco australia ltd - disopyramide, quantity: 150 mg - capsule, hard - excipient ingredients: magnesium stearate; maize starch; purified talc; gelatin; titanium dioxide; pregelatinised maize starch - management of documented ventricular arrhythmias, e.g. sustained ventricular tachycardia, which are judged to be life threatening. because of its proarrhythmic potential, the use of disopyramide is not recommended for lesser arrhythmias. treatment of asymptomatic ventricular premature contractions should be avoided. in patients with structural heart disease, proarrhythmia and cardiac decompensation are a special risk associated with antiarrhythmic drugs. special caution should be exercised when prescribing disopyramide for these patients. (see precautions.)
angiomax
pharmacy retailing (nz) ltd t/a healthcare logistics - bivalirudin 250mg - powder for injection - 250 mg - active: bivalirudin 250mg excipient: mannitol sodium hydroxide - angiomax is indicated for use as an anticoagulant: · in the treatment of patients with moderate to high risk acute coronary syndromes (acs) (unstable angina/non-st segment elevation myocardial infarction (ua/nstemi) who are undergoing early invasive management, and · in patients undergoing percutaneous coronary intervention (pci). angiomax is intended for use with aspirin. a p2y12 antagonist (eg clopidogrel or ticlopidine) may be used in addition to aspirin.
cancidas
merck sharp & dohme (new zealand) limited - caspofungin acetate 57.8mg equivalent to 50 mg caspofungin anhydrous free base; - powder for infusion - 50mg + transfer set - active: caspofungin acetate 57.8mg equivalent to 50 mg caspofungin anhydrous free base excipient: glacial acetic acid mannitol sodium hydroxide sucrose water for injection